News

A vehicle is donated in favor Of ANT and it will be used for home assistance to sick people and for social transport

Neupharma took part to the charity collection of pharmaceutical products in order to help Cystic Fibrosis patients in war-affected areas

Neupharma celebrates its 10th corporate anniversary with a new cover image

DKD obtained approval as Food for Special Medical Purposes for Osteogenesis Imperfecta, Ehlers-Danlos Syndrome, Deficiency Rickets

Neupharma Team wishes our website users merry Christmas and a happy new year 2022

Neupharma and Davide Fiumi (CEO) honoured for "Corporate Social Responsibility in Healthcare"

Neupharma Srl will sponsor a summer leg of the “MiFidoDiTe” charity project during the Italian Open Water Tour 2021

Neupharma announces the positive conclusion of the phase 1 study, conducted at the “Azienda Ospedaliera Universitaria Integrata” of Verona, with the formulation of inhaled teicoplanin in CF patients.

The German Quality and Finance Institute published the results of the research entitled "Champions of Growth": the aim was rewarding the 400 companies whose turnover increased most in the three-year period 2016-2019.